These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37824525)

  • 1. Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai.
    Zhang J; Tan S; Peng C; Xu X; Wang M; Lu W; Wu Y; Sai B; Cai M; Kummer AG; Chen Z; Zou J; Li W; Zheng W; Liang Y; Zhao Y; Vespignani A; Ajelli M; Lu X; Yu H
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2306710120. PubMed ID: 37824525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level.
    Zheng JX; Lv S; Tian LG; Guo ZY; Zheng PY; Chen YL; Guan SY; Wang WM; Zhang SX
    Infect Dis Poverty; 2022 Nov; 11(1):114. PubMed ID: 36434701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
    Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jul; ():. PubMed ID: 35898339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    Lancet Reg Health West Pac; 2022 Dec; 29():100592. PubMed ID: 36090701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
    Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2800-2807. PubMed ID: 36205530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
    Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
    Chang H; Zhang X; Su H; Cai J; Liu X; Li J; Wang Y; Zhang Z; Zhu M; Zhao L; Zhang S; Mei K; Zhang L; Wang X; Yan H; Luo L; Xu Z; Zeng M
    Epidemiol Infect; 2023 May; 151():e81. PubMed ID: 37142552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.
    Meo SA; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9470-9476. PubMed ID: 37843359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai.
    Wu Q; Wang H; Cai J; Ai J; Li Y; Zhang H; Wang S; Sun F; Wu Y; Zhou J; Wang Y; Yu H; Zhang W
    Emerg Microbes Infect; 2023 Dec; 12(1):e2169197. PubMed ID: 36644859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai.
    Fu Z; Liang D; Zhang W; Shi D; Ma Y; Wei D; Xi J; Yang S; Xu X; Tian D; Zhu Z; Guo M; Jiang L; Yu S; Wang S; Jiang F; Ling Y; Wang S; Chen S; Liu F; Tan Y; Fan X
    Front Med; 2023 Jun; 17(3):562-575. PubMed ID: 36949347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
    Cheng VCC; Ip JD; Chu AWH; Tam AR; Chan WM; Abdullah SMU; Chan BPC; Wong SC; Kwan MYW; Chua GT; Ip P; Chan JMC; Lam BHS; To WK; Chuang VWM; Yuen KY; Hung IFN; To KKW
    Clin Infect Dis; 2022 Aug; 75(1):e44-e49. PubMed ID: 35271728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Associated with the Spatiotemporal Spread of the SARS-CoV-2 Omicron BA.2 Variant - Shanghai Municipality, China, 2022.
    Zheng W; Deng X; Peng C; Yan X; Zheng N; Chen Z; Yang J; Ajelli M; Zhang J; Yu H
    China CDC Wkly; 2023 Feb; 5(5):97-102. PubMed ID: 37006708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal control strategies of SARS-CoV-2 Omicron supported by invasive and dynamic models.
    Rui J; Zheng JX; Chen J; Wei H; Yu S; Zhao Z; Wang XY; Chen MX; Xia S; Zhou Y; Chen T; Zhou XN
    Infect Dis Poverty; 2022 Nov; 11(1):115. PubMed ID: 36435792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological characteristics of first-time SARS-CoV-2 Omicron infection among hospital staff in Chengdu, China.
    Tang L; Wang Y; Li X; Yang L; Luo Y; Li C; He Y
    J Health Popul Nutr; 2024 Jul; 43(1):104. PubMed ID: 38978145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron variants in China.
    Peng L; Huang X; Wang C; Xin H; Cowling BJ; Wu P; Tsang TK
    Epidemiol Infect; 2024 Mar; 152():e43. PubMed ID: 38500342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of SARS-CoV-2 Omicron BA.5 Infections, Macau, June-July 2022.
    Xiong W; Peng L; Tsang TK; Cowling BJ
    Emerg Infect Dis; 2023 Feb; 29(2):453-456. PubMed ID: 36648122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.